Arcutis Expands Board of Directors with Appointment of Chris Peetz
Arcutis appointed Christopher Peetz to its Board of Directors effective July 15, 2026, adding a veteran executive with significant experience in biopharmaceutical growth and M&A. Peetz currently serves as CEO of Mirum Pharmaceuticals and previously led Tobira through its acquisition by Allergan, bringing expertise in commercialization and strategic scaling.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.